Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Kids with chronic conditions walk stronger with VR at home

NCT ID NCT07021638

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new home-based program that uses a special treadmill and virtual reality to help children with conditions like cerebral palsy, muscle diseases, or obesity improve their walking. About 30 children aged 6 to 17 will try the program at home for at least 3 sessions per week. The goal is to see if it's safe, doable, and helps their strength and daily activities.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient aged 6 to 17 years at date of inclusion; * Able to walk for 5 minutes on a treadmill with or without body weight support, with or without technical aids; * Be able to understand and play virtual reality games (immersive or non-immersive); * Be able to answer questionnaires; * Patient affiliated to or benefiting from a social security scheme; * Informed consent, dated and signed by parents or guardians (if minors), to participate in the study; * Included in a care program specific to their chronic condition for at least 6 months; * Meet the following criteria depending on the group: PC group: * Diagnosis of CP * Functional level classified II or III according to the Gross Motor Function Classification System (GMFCS) * Rehabilitation goal: improvement of gait and/or gross motor function OB group: * Overweight or obese, defined by a BMI above the IOTF-25 percentile * Aim to increase daily physical activity * No history of hip pathology Group NM: * Diagnosis of one of the following neuromuscular pathologies: spinal muscular atrophy type 3, Duchenne disease, congenital myopathy or Charcot Marie Tooth. * Functional level of grade 2 to 6 on the Walton scale, or grade 3 to 7 on the Vignos scale * Rehabilitation goal: improvement of walking and/or gross motor skills Exclusion Criteria: * Patients weighing over 100 kg (due to the technical constraints of using the AMY mat). * For children aged 6 to 11: in connection with the immersive virtual reality device: problems with stereoscopic vision (perception of images in 3 dimensions), unstabilized epilepsy, facial trauma \< 3 months, hearing or visual impairment, pain, dizziness or nausea caused by using immersive virtual reality. * Patients who have undergone surgery in the last 3 months; * Patients who have received intramuscular botulinum toxin injections in the lower limbs or intensive therapy in the 3 months prior to inclusion; * Patient with a non-routine therapeutic program planned within 5 months that could lead to confusion with the tested program; * Patient with insufficient understanding of the French language; * Patient opposition (child or adolescent); * Persons deprived of liberty by judicial or administrative decision; * Persons under compulsory psychiatric care; * Persons under legal protection;

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Amy treadmill are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Les Capucins

    RECRUITING

    Angers, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.